Unique ID issued by UMIN | UMIN000023438 |
---|---|
Receipt number | R000027007 |
Scientific Title | A Procedureless Intra-gastric Diet Balloon Capsule |
Date of disclosure of the study information | 2016/08/05 |
Last modified on | 2020/02/14 12:37:40 |
A Procedureless Intra-gastric Diet Balloon Capsule
A Swallowable Balloon Capsule for Bariatric Therapy (BCBT)
A Procedureless Intra-gastric Diet Balloon Capsule
A Swallowable Balloon Capsule for Bariatric Therapy (BCBT)
Japan |
Obesity
Medicine in general | Gastroenterology | Endocrinology and Metabolism |
Others
NO
To establish a non-invasive, patient-friendly and simple bariatric therapy for preventing comorbidities due to obesity.
Others
To validate that this method is so efficient as at reducing body weight as conventional intra-gastric bariatric balloons implanted using endoscopic assistance.
Confirmatory
Pragmatic
Phase III
Reducing rate of the excess body weight before and after the trial
1. Reducing the amount of internal fat tissue which will be evaluated by a CT scan before and after the trial.
2. Efficacy of glucose tolerance and hyperlipidemia 16 weeks after ingestion
3.Changes in the microbiota in the gut using 16S rRNA fecal analysis 16 weeks after ingestion
4.Evaluation of adverse reactions
Interventional
Cross-over
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Device,equipment |
Two arm cross-over trial
Arm1: A swallowable balloon capsule (volume 400ml filled with CO2) implanted for 4 months in the stomach
Arm2: A placebo balloon capsule ( not inflatable due to holes in it ) is ingested
4 months later after excreting the first balloon,
Arm1: placebo balloon capsule.
Arm2: real swallowable balloon capsule
15 | years-old | <= |
80 | years-old | > |
Male and Female
1.Patients with a BMI more than 30
2.Patients with a BMI between 25 and 30 who have a past history of, or are presently having treatment for diabetes, hyperlipidemia (LDL-C over 200), angina pectoris, cerebral infarction or NASH (Non- alcoholic steatohepatitis).
1. Patients undergoing insulin therapy or patients with conditions such as chronic heart failure or chronic renal failure, which would make it very difficult for them to improve physical activity levels.
2. Patients who cannot ingest capsules
3. Patients who have a rubber allergy
4. Patients who have their digestive tract altered by surgery or have a high risk of ileus or stenosis due to stricture in the gastrointestinal tract.
5. Patients who have an implant such as a cardiac pace-maker.
6. Patients who will not allow the doctor to perform an endoscopic procedure in an emergency.
20
1st name | |
Middle name | |
Last name | Hidetoshi Ohta |
Sapporo Orthopaedics and Cardiovascular Hospita
Gastroenterology
1-2-11-30 Kitano, Kiyota-ku,
011-881-1100
hideohta@true.ocn.ne.jp
1st name | |
Middle name | |
Last name | Masami Sasaki |
Sapporo Orthopaedics and Cardiovascular Hospital
Committee for Clinical Trial and Institutional Review Board
1-2-11-30 Kitano, Kiyota-ku, Sapporo, Japan
011-881-1100
sasaki26314@yahoo.co.jp
Sapporo Orthopaedics and Cardiovascular Hospital
Sapporo Orthopaedics and Cardiovascular Hospital
Self funding
Japan
Sapporo Shiroishi Memorial Hospital,
Otaru Ekisaikai Hospital
NO
札幌整形循環器病院(北海道)、札幌白石記念病院(北海道)、小樽掖済会病院(北海道)
2016 | Year | 08 | Month | 05 | Day |
Unpublished
Completed
2016 | Year | 05 | Month | 07 | Day |
2016 | Year | 04 | Month | 30 | Day |
2016 | Year | 08 | Month | 05 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 05 | Month | 01 | Day |
2016 | Year | 08 | Month | 01 | Day |
2020 | Year | 02 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027007
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |